Start Date
Immediate
Expiry Date
14 May, 25
Salary
0.0
Posted On
14 Feb, 25
Experience
3 year(s) or above
Remote Job
No
Telecommute
No
Sponsor Visa
No
Skills
Disabilities, Disability Insurance, Empower, Resumes, Biochemistry, Communication Skills, Chemistry, Development Strategy, Biologics
Industry
Pharmaceuticals
IN 2024, EUROFINS GENERATED TOTAL REVENUES OF EUR 6.515 BILLION, AND HAS BEEN AMONG THE BEST PERFORMING STOCKS IN EUROPE OVER THE PAST 20 YEARS.
Eurofins CDMO Alphora Inc. develops and manufactures new therapeutics to improve the lives and health of patients. Eurofins CDMO Alphora provides contract research & development services to global pharmaceutical and biotech companies, developing their processes and manufacturing their bulk drug substances (Active Pharmaceutical Ingredients -“API’s”) as well as finished dosage products (tablets, capsules, suspensions) for supply to clinical trials and commercial requirements. Eurofins CDMO Alphora provides a rich and technologically challenging environment with a continuing flow of interesting projects. Our employees work in close concert with clients throughout the development process to achieve their program objectives. Eurofins CDMO Alphora Inc. is growing its state-of-the-art organization, with continued investments in modern facilities, equipment, and instrumentation while providing a rich environment for employees to develop their technical skills and careers paths.
Job Description
The Scientist in Analytical Development is responsible for being a team lead in the development of analytical development for biologics and therapeutics by assuming crucial role in the design and execution of a complete analytical testing. The scientist is accountable to the Manager, Analytical Development in Biologics to execute/report on analytical development activities, including technology transfer, planning and execution of technology/method transfer, early/late-stage method development/testing within the Biologics Business Unit to meet the business objectives.
QUALIFICATIONS